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Abstract
Congenital abnormalities of the kidney and urinary tract (CAKUT) account for approximately half
of children with chronic kidney disease and they are the most frequent cause of end-stage renal
disease in children in the US. However, its genetic etiology remains mostly elusive. VACTERL
association is a rare disorder that involves congenital abnormalities in multiple organs including
the kidney and urinary tract in up to 60% of the cases. By homozygosity mapping and whole
exome resequencing combined with high-throughput mutation analysis by array-based multiplex
PCR and next-generation sequencing, we identified recessive mutations in the gene TNF receptor-
associated protein 1 (TRAP1) in two families with isolated CAKUT and three families with
VACTERL association. TRAP1 is a heat shock protein 90-related mitochondrial chaperone
possibly involved in antiapoptotic and endoplasmic reticulum-stress signaling. Trap1 is expressed
in renal epithelia of developing mouse kidney E13.5 and in the kidney of adult rats, most
prominently in proximal tubules and in thick medullary ascending limbs of Henle’s loop. Thus, we
identified mutations in TRAP1 as highly likely causing CAKUT or CAKUT in VACTERL
association.
Introduction
Congenital abnormalities of the kidney and urinary tract (CAKUT) occur in 3–6 per 1,000
live births. CAKUT are the most frequent cause for chronic kidney disease in children
(~50%)1, 2 in the US. The acronym “CAKUT” comprises heterogeneous malformations
involving the kidney (e.g. renal agenesis, hypodysplasia), and the urinary tract (e.g.
vesicoureteral reflux, ureteropelvic junction obstruction)3. These congenital anomalies are
related because a part of their pathogenesis is an impaired co-development of nephrogenic
tissues derived from the metanephric mesenchyme and the ureteric bud4. Twenty monogenic
causes of isolated CAKUT in humans have been published to date as reviewed recently by
Yosypiv5. However, they only account for ~10% - 20% of all cases indicating a broad
genetic heterogeneity of CAKUT. A recent study on copy number variations (CNVs) in a
large cohort of individuals with CAKUT and two publications identifying novel monogenic
causes of CAKUT bring further evidence that CAKUT is a condition of extensive genetic
heterogeneity6–8. CAKUT most frequently occur isolated, but might be associated with
extra-renal phenotypes, for instance with VACTERL association (MIM [#192350]). The
acronym “VACTERL” describes the combination of at least three of the following
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tcongenital anomalies: vertebral defects (V), anorectal malformations (A), cardiac defects
(C), tracheoesophageal fistula with or without esophageal atresia (TE), renal malformations
(R), and limb defects (L). VACTERL association is a rare disease that occurs mostly
sporadic in 1/10,000–40,000 live births9. Its etiology is enigmatic, although animal models
suggest an involvement of Sonic hedgehog signaling10. In humans, ZIC3 mutations are the
cause of a closely related non-classic VACTERL condition (VACTERL-X, MIM
[#314390])11, 12. Additionally, there are six case reports published of individuals with
VACTERL association in conjunction with mitochondrial dysfunction as summarized
recently by Siebel and Solomon13. In order to identify new recessive genes that cause
isolated CAKUT or CAKUT in VACTERL association, we performed homozygosity
mapping and whole exome resequencing in 24 affected individuals with CAKUT from 16
families, and in 4 individuals with CAKUT in VACTERL.
Results
Whole exome resequencing identifies a homozygous mutation in TRAP1 in CAKUT and in
VACTERL association
By homozygosity mapping in a family of two sibs (A3403) with unilateral and bilateral
vesicoureteral reflux (VUR) III°, respectively (Figure 1A, B and Table 1), we identified a
short 5.2 Mb segment of homozygosity on chromosome 5 (Figure 1C), indicating distant
consanguinity of the parents. This finding suggested that in this family CAKUT are most
likely caused by a homozygous recessive mutation in an unknown CAKUT gene. We
performed whole exome resequencing in individual A3403-21 as described previously by
the authors14, 15. In order not to miss either a homozygous mutation in a short run of
homozygosity or a compound heterozygous mutation (which, as in this case, cannot be
excluded a priori in families with remote consanguinity16), we considered variants not only
in the homozygosity peak but within regions of genetic linkage for both sibs (coverage ≥ 4;
minor variant frequency, MVF ≥ 0.2). Following variant filtering we retained 38 variants in
13 genes for Sanger confirmation and segregation analysis (Supplementary Table S1
online). Only a single homozygous missense mutation (R469H) in the gene TRAP1 on
chromosome 16p13.3 survived the variant filtering process and segregation analysis (Figure
1D). This homozygous variant in TRAP1 in A3403-21 and -22 was positioned in a ~1.5 Mb
run of apparent homozygosity that was not detected by homozygosity mapping (Figure 1C),
because the threshold for detection of “homozygosity peaks” is 2.1 Mb17.
In family A4252 with CAKUT in VACTERL we performed whole exome resequencing in
an affected individual (A4252-21). This girl was born with a right double kidney and duplex
ureter, left VUR, esophageal atresia type IIIb, and anal atresia with a vestibular fistula
(Figure 1E, F and Table 1). Although there was no consanguinity reported in this family,
homozygosity mapping showed unusually broad homozygosity peaks on chromosome 16 on
the p-terminus and q-terminus (5.5 and 9.6 Mb, respectively) (Figure 1G). In this case, we
hypothesized that CAKUT in VACTERL is caused by a homozygous mutation within these
homozygous regions. When evaluating whole exome resequencing data in this individual,
the 512,733 variants initially detected (MVF ≥ .55; coverage ≥ 2) were reduced to only 11
variants within the “homozygosity peaks” on chromosome 16 and 18 (Supplementary Table
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tS2 online). The only variant that was confirmed by Sanger sequencing and that altered a
conserved amino acid residue was TRAP1 R469H, the same allele as in family A3403. By
comparison of SNPs in the affected girl and her parents, we demonstrated that partial
maternal isodisomy of chromosome 16 with two recombinants (one located on the p-arm
and one located on the q-arm) was the underlying cause of homozygosity for TRAP1 R469H
(Figure 1G-J).
The TRAP1 allele c.1406G>A, p.R469H alters an evolutionary highly conserved amino acid
residue and it is predicted to be deleterious for protein function by publically available
software programs (Table 1 and Supplementary Figure S1 online). In the Exome Variant
Server (EVS) database, R469H has a minor allele frequency (MAF) of 0.9% in Americans
of European descent. In our cohort of 675 individuals with CAKUT, most of them
European, the MAF is 1.9%. The three affected individuals from two unrelated families with
homozygous TRAP1 R469H, as well as 6 additional heterozygous carriers share haplotypes
at the TRAP1 locus (Figure S2 online) which speaks for TRAP1 R469H being a European
founder mutation.
Mutation analysis reveals three additional families with TRAP1 mutations
We subsequently analyzed the coding sequence of TRAP1 in a cohort of 675 individuals
with isolated CAKUT (Supplementary Table S3 online) and 300 individuals with classic
VACTERL association (i.e. VACTERL-X and other related disorders have been excluded)
using a barcoded multiplex PCR approach and consecutive next generation sequencing as
described previously by the authors18. As a control group, we included 800 individuals with
the distinct renal phenotype of nephronophthisis.
We detected six additional recessive mutations in TRAP1 in a compound heterozygous state
in three additional unrelated families with CAKUT or CAKUT in VACTERL (Table 1,
Figure 1K, L, M, Supplementary Figure S1, and S3 online). In individual A3051-21 with a
left-sided multicystic dysplatic kidney (MCDK), we found a maternally inherited protein-
truncating frame-shift mutation (c.127_137dup, p.R46fs*75). This mutation abrogates the
N-terminal mitochondrial targeting sequence of TRAP1, which makes this a null allele. The
second allele was a missense mutation (c.1324G>A, p.E442K) which segregated from the
father.
In individual A4884-21 with CAKUT in VACTERL, including right renal agenesis,
vertebral malformations, anal atresia with a rectoperineal fistula, atrial septum defect type II,
esophageal atresia, and abnormal position of the thumbs (Table 1 and Supplementary Figure
S4 online), we detected compound heterozygous missense mutations in TRAP1 located in
the ATPase-domain (c.757A>G, p.I253V) and in the HSP90-domain (c.1573C>T, p.L525F)
(Figure 1L).
In individual EA1717 with CAKUT in VACTERL, including pyelectasis, left VUR, a
complex anorectal malformation including anal atresia and persistent cloaca, esophageal
atresia, cardiac defects, limb defects and, persistent left vena cava superior (Table 1), we
detected compound heterozygous missense mutations which are both located in the HSP90-
domain of TRAP1 (c.1330T>A, p.Y444N and c.1663G>A, p.V555I).
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tIn order to exclude the presence of recessive mutations in controls, we sequenced the TRAP1
coding sequence in 800 individuals with the distinct renal phenotype of nephronophthisis
(NPHP). We detected the TRAP1 allele I253V seven times (MAF 0.87%), T444N twice
(MAF 0.25%), and R469H twice (MAF 0.025%), all of them as single heterozygous alleles.
TRAP1 R46Sfs*75, E442K, L525F, and V555I were absent from our control cohort.
Furthermore, no other possibly deleterious variants were present in a homozygous or
compound heterozygous state in 800 individuals with NPHP.
Trap1 is expressed in developing and adult kidney
In order to determine whether TRAP1 has a function during kidney development, we
analyzed Trap1 expression in developing kidney in mouse embryos 13.5 dpc. Trap1
expression seemed to be expressed at this stage in renal vesicles according to Trap1
transcription assays publically available through the Gudmap project. By in-situ
hybridization in E13.5 mouse embryos, we found Trap1 to be strongly expressed in kidney,
adrenal gland, and gonad. Trap1 expression specifically localized to renal epithelia (Figure
2).
In order to characterize TRAP1 localization in adult kidney, we performed
immunofluorescence stainings in rat using a monoclonal TRAP1 antibody in conjunction
with established renal markers (Figure 3). TRAP1 is present most prominently in peanut-
lectin-marked proximal tubules in the renal cortex (Figure 3A-B). In renal medulla, we
detected TRAP1 in peanut-lectin-negative tubular segments and in NKCC-marked
(Na+K+2Cl− co-transporter) thick ascending limbs of Henle’s loop (Figure 3C-D). TRAP1
co-localizes with mitochondrial marker MTCO1 in renal cortex and medulla.
Discussion
In the present study, we identified by whole exome resequencing and high-throughput
mutation analysis five unrelated families with CAKUT or CAKUT in VACTERL
association with recessive mutations in TRAP1. Two sibs with CAKUT had a homozygous
missense mutation (R469H), which segregated from a common ancestor of their parents. A
girl with VACTERL association had the identical homozygous mutation due to maternal
isodisomy of chromosome 16 p-ter and q-ter. In a cohort of 675 individuals with CAKUT
and 300 individuals with classic VACTERL association we identified 3 additional
individuals carrying compound heterozygous mutations in TRAP1. Homozygous or
compound heterozygous deleterious variants were absent from 800 control individuals. By
ISH and IF, we showed that Trap1 is expressed in early mouse renal epithelia whereas the
Trap1 protein is present only in defined segments of developed nephrons in rat.
In 6,500 individuals recorded in the EVS server there are several nonsynonymous variants
present in TRAP1, including heterozygous truncating variants in 11 individuals. However,
deleterious alleles in recessive disease-genes, unlike in dominant disease-genes, do not
underlie direct negative selection through evolution. Consequently the presence of rare
deleterious variants in recessive disease genes in a large cohort is an expected finding.
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with CAKUT in VACTERL, is present homozygously in a single individual of the ESP
cohort of 6,500 healthy Americans. However, in the context of CAKUT, this does not
necessarily mean the variant is non-pathogenic. CAKUT frequently remain completely
asymptomatic. For instance, a double-kidney or unilateral renal agenesis typically are an
“accidental finding” in renal ultrasound.
The fact that the homozygous mutation TRAP1 R469H was found in an individual with
CAKUT and an individual with VACTERL association is surprising. However, in CAKUT
and in VACTERL association intra-familial phenotypic variability is very common19–21.
Even in a single individual different CAKUT phenotypes may be present, for instance left
renal agenesis and right VUR.
The frequencies of individuals with recessive TRAP1 mutations in our cohorts (0.15% in
CAKUT, 0.6% in CAKUT with VACTERL) suggest that mutations in TRAP1 are a rare
cause of these conditions. Similarly, mutations in two recently identified CAKUT-causing
genes, WNT4 and DSTYK, are rare causes of CAKUT7, 8. These findings in humans, along
with numerous CAKUT-mouse models, indicate that CAKUT are a common clinical
phenotype arising from a multitude of different single-gene causes.
In conclusion, we propose that recessive mutations in TRAP1 are a novel rare cause of
isolated CAKUT and the first recessive cause of the VACTERL association.
Subjects and Methods
Human subjects
We obtained blood samples and pedigrees following informed consent from individuals with
CAKUT and from individuals with VACTERL association. Approval for human subjects
research was obtained from the University of Michigan Institutional Review Board and
other institutions involved. The diagnosis of CAKUT and VACTERL association was based
on published clinical criteria9.
Homozygosity mapping
We performed homozygosity mapping as described previously17.
Whole exome resequencing (WER)
Exome library preparation and massively parallel resequencing was conducted using the
SeqCap EZ Exome v2 (Nimblegen) and Genome Analyzer II (Illumina). Subsequent variant
detection, filtering and analysis have been described previously by the authors14, 15. All
detected variants were confirmed by Sanger sequencing.
Immunofluorescence microscopy (IF)
IF was performed as previously described by the authors14 using a Leica SP5X system with
an upright DM6000 compound microscope and images were processed with the Leica AF
software suite. Antibodies used: TRAP1 (Abcam, [TRAP1-6], Cat# ab2721), MTCO1
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t(Abcam Cat# ab45918), NKCC2 (LSBio Cat# LS-C150446), NCCT (Millipore Cat#
AB3553). Specificity of the anti-TRAP1 antibody for rat TRAP1 was confirmed in
immunoblot (Figure S5 online).
In-situ hybridization (ISH)
ISH was conducted on sections of wildtype mouse embryos with an NMRI background at
embryonic day 13.5. Mouse embryos were dissected into ice cold phosphate buffered saline
(PBS), fixed overnight in 4% paraformaldehyde/PBS, and then processed into paraffin wax.
ISH was performed on paraffin sections (5]m) using antisense probes generated by PCR
from an E11.0 total embryo cDNA library, and specific staining was verified using a sense
probe. PCR products contained 3’ T7 and 5’ T3 RNA polymerase binding sites for in vitro
transcription and probes were purified using G-50 sephadex columns (GE Healthcare). The
779bp probe for Trap1 spans exons 13–17 (Accession: NM_026508.2).
ISH was performed according to the protocol from (Chotteau-Lelievre et al., 2006) with
minor modifications, and detection of AP activity was visualized using BM Purple (Roche
Diagnostics). Following staining, slides were quickly dehydrated in 80% and then 100%
ethanol, cleared twice for 1 min in xylene (Roth) and coverslips were mounted with Entellan
mounting medium (Merck). Photographs were obtained using AxioVision software (Zeiss)
with a Zeiss AxioCam and SteREO Discovery.V12 microscope. Three sections from at least
2 different embryos were analyzed.
Bioinformatics
NGS reads alignment and variant detection was done with Genomics Workbench software
(CLC Biotech). Mapping parameter: Global alignment, length fraction = 0.9, and similarity
fraction = 0.9. Genetic location is according to the assembly of the Genome Reference
Consortium GRCh37.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Homozygosity mapping and whole exome resequencing identifies mutations in TRAP1
as causing CAKUT or VACTERL association
(A, B) Voiding cysturethrograms (VCUG) of CAKUT siblings A3403-21 and -22 showing
unilateral vesicoureteral reflux (VUR) grade III and bilateral VUR, respectively (white
arrow heads).
(C) Non-parametric LOD (NPL) scores across the human genome in 2 affected sibs. X-axis
represents Affymetrix 250k StyI array SNP positions across human chromosomes
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tconcatenated from p-terminal (left) to q-terminal (right). Genetic distance is given in cM. A
single peak indicates distantly related parents.
(D) Chromatogram of newly identified homozygous missense mutation (arrow head) in the
gene encoding TNF receptor-associated protein 1 (TRAP1) over wild type control.
(E) VCUG (upper panel) and cystoscopy (lower panel) demonstrating VUR and a dilated
ureteral orifice, respectively.
(F) Chest X-ray (top panel) and esophagoscopy (bottom panel) showing esophageal atresia
and esophagotracheal fistula in individual A4252-21 with CAKUT in VACTERL
association.
(G) NPL score in an individual A4252-21 with VACTERL association. Two maximum
peaks indicate homozygosity at the p-terminus and q-terminus of chromosome 16.
(H) Panel on the right illustrates maternal heterodisomy of chromosome 16 and partial
uniparental isodisomy (p-ter and q-ter) of the child (Fa, father; Mo, mother; Ch, child).
(I) Partial haplotypes of selected markers and their physical positions across chromosome 16
in the father (Fa), the mother (Mo), and the affected child (Ch) of CAKUT family A4252.
Selected markers (biallelic SNPs; MAF = 0.496 – 0.5) homozygous in the father are shown
in green (alleles AA) and light green (alleles BB).
The fact that for 19 of 52 alleles there is paternal non-contribution in the child strongly
suggests maternal heterodisomy of chromosome 16. No paternal non-contribution was
observed in the child on any other chromosome (data not shown).
(J) Selected markers (biallelic SNPs; MAF = 0.497 – 0.5) heterozygous in the mother (Mo)
of family A4252 are shown for alleles coded in red (AB; phase unknown). Note that in the
central segment (b), separated by vertical lines, the child’s (Ch) haplotype is identical to the
mother’s. In the p-ter (a) and q-ter (a’) segments (a, a’) the child is homozygous, indicating
maternal isodisomy in these segments.
(K) Exon structure of human TRAP1 cDNA. Positions of start codon (ATG) and of stop
codon (TGA) are indicated.
(L) Domain structure of the TRAP1 protein. HSP, heat shock protein; MTS, mitochondrial
targeting sequence.
(M) Translational changes of detected mutations are shown relative to their positions in
TRAP1 cDNA (see L) and TRAP1 protein (see M) for affected individuals with CAKUT or
CAKUT in VACTERL association with recessive TRAP1 mutations. Family numbers are
shown in parenthesis. (* denotes an individual carrying a compound hete)
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tFigure 2. Trap1 is highly expressed in renal epithelia of E13.5 mouse embryos
The upper panel shows an HE-stained sagittal section (A) and a Trap1-ISH (A’) in
consecutive sections of a mouse embryo E13.5. Note the prominent Trap1 expression in the
developing kidney (marked “Ki” in the left panel). The lower panel shows higher
magnifications of E13.5 mouse kidney. (B) HE staining, (B’) Trap1-ISH. The Trap1-ISH
staining pattern in consistent with Trap1 being expressed specifically in renal epithelia (B’).
Ag, adrenal gland; Go, gonad; HE, hematoxylin-eosin; ISH, in-situ hybridization; Ki, kidney
(i.e. metanephros); Li, liver; Lu, lung; Mg, midgut; Pa, pancreatic primordium.
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tFigure 3. Trap1 is highly expressed in renal epithelia of E13.5 mouse embryos
The upper panel shows an HE-stained sagittal section (A) and a Trap1-ISH (A’) in
consecutive sections of a mouse embryo E13.5. Note the prominent Trap1 expression in the
developing kidney (marked “Ki” in the left panel). The lower panel shows higher
magnifications of E13.5 mouse kidney. (B) HE staining, (B’) Trap1-ISH. The Trap1-ISH
staining pattern in consistent with Trap1 being expressed specifically in renal epithelia (B’).
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tAg, adrenal gland; Go, gonad; HE, hematoxylin-eosin; ISH, in-situ hybridization; Ki, kidney
(i.e. metanephros); Li, liver; Lu, lung; Mg, midgut; Pa, pancreatic primordium.
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